Huatai Securities announced the Hong Kong stock strategy, stating that at the macro level, the global liquidity environment is still uncertain, suppressing room for further restoration of Hong Kong stock valuations. Therefore, it continues to recommend using low-wave dividends as bottom positions, such as banks, utilities, etc.; at the same time, controlling allocation exposure for beta varieties with high US bond yields, such as color. The positive change is in financial reports. The profit growth rate of all Hong Kong stocks rebounded sharply year-on-year in the first half of 2026. However, due to internal segmentation, the profit growth rate of high dividends was positive, mainly driven by resource products. Continued to be tested. Innovative drugs continued to increase rapidly, while the negative increase on the Internet increased. Judging from financial reports and responses to interest rate hikes expectations, it continues to be recommended to hold innovative drugs and CXO leaders with both performance delivery and financial recognition. Necessary consumption such as food and drink, as previously indicated, is running on the right side of the bottom of the fundamentals as scheduled, but there is a lack of catalysis in the short term, so be patient.

Zhitongcaijing · 1d ago
Huatai Securities announced the Hong Kong stock strategy, stating that at the macro level, the global liquidity environment is still uncertain, suppressing room for further restoration of Hong Kong stock valuations. Therefore, it continues to recommend using low-wave dividends as bottom positions, such as banks, utilities, etc.; at the same time, controlling allocation exposure for beta varieties with high US bond yields, such as color. The positive change is in financial reports. The profit growth rate of all Hong Kong stocks rebounded sharply year-on-year in the first half of 2026. However, due to internal segmentation, the profit growth rate of high dividends was positive, mainly driven by resource products. Continued to be tested. Innovative drugs continued to increase rapidly, while the negative increase on the Internet increased. Judging from financial reports and responses to interest rate hikes expectations, it continues to be recommended to hold innovative drugs and CXO leaders with both performance delivery and financial recognition. Necessary consumption such as food and drink, as previously indicated, is running on the right side of the bottom of the fundamentals as scheduled, but there is a lack of catalysis in the short term, so be patient.